Product Images Desvenlafaxine

Each film-coated tablet contains desvenlafaxine succinate, an extended-release medication used to treat depression. The tablet is equivalent to 100 mg of desvenlafaxine. The recommended dosage can be found in the package insert. It is important to swallow the tablet whole and not crush, cut, chew, or dissolve it. The tablets should be stored at a controlled room temperature between 20°C and 25°C (68°F and 77°F). The medication guide can be printed from the website www.advagenpharma.com/medguide/desvenlafaxineextendedreleasetablets. It is essential to keep the tablets out of the reach of children. The product is manufactured by Rubicon Research Private Limited in Ambernath, India and distributed by Advagen Pharma Limited in Plainshoro, NJ, USA. The pharmacist should dispense the accompanying medication guide to each patient. This particular package contains 1000 tablets.*

The text describes a medication called Desvenlafaxine Extended-Release Tablets. Each tablet contains 152 mg of desvenlafaxine succinate, which is equivalent to 100 mg of desvenlafaxine. The usual dosage instructions can be found in the package insert. The tablets should be swallowed whole and should not be crushed, cut, chewed, or dissolved. The medication should be stored at a temperature of 20° to 25°C. A medication guide can be printed from the website www.advagenpharma.com/medguide/desvenlafaxineextendedreleasetablets. It is important to keep this medication and all drugs out of the reach of children. The medication is distributed by Advagen Pharma Limited in Plainsboro, NJ, USA, and manufactured by Rubicon Research Private Limited in India.*

This is a description of a medication called Desvenlafaxine Extended-Release Tablets. Each tablet contains 152 mg of desvenlafaxine succinate, which is equivalent to 100 mg of desvenlafaxine. The usual dosage should be determined based on the package insert. It is important to swallow the tablets whole and not crush, cut, chew, or dissolve them. The tablets should be stored at a temperature of 20° to 25°C (68° to 77°F). The medication guide can be printed from the website www.advagenpharma.com/medguide/desvenlafaxineextendedreleasetablets. It is crucial to keep this and all drugs out of the reach of children. The product is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. This information is for pharmacists who should dispense the accompanying medication guide to each patient. The product comes in a package of 90 tablets.*

This text is a description for a medication called Desvenlafaxine Extended-Release Tablets. Each film-coated tablet contains 76 mg of desvenlafaxine succinate, which is equivalent to 50 mg of desvenlafaxine. The usual dosage and administration instructions can be found in the package insert. It is important to swallow the tablets whole and not crush, cut, chew, or dissolve them. The tablets should be stored at a temperature of 20° to 25°C (68° to 77°F) according to USP Controlled Room Temperature guidelines. The medication guide can be printed from the website provided. It is essential to keep this medication and all drugs away from children. The National Drug Code (NDC) for these tablets is 72888-143-00. The pharmacist should dispense the accompanying Medication Guide to each patient. The medication is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in Ambernath, India.*

This text appears to be a description of a medication called Desvenlafaxine Extended-Release Tablets. The tablets are film-coated and should be swallowed whole without crushing, cutting, chewing, or dissolving. Each tablet contains 76 mg of desvenlafaxine succinate, which is equivalent to 50 mg of desvenlafaxine. The recommended dosage can be found in the package insert. The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F). The medication is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. The text also includes information on the medication guide, precautions for keeping it out of reach of children, and the NDC number.*

This is a description of a medication called Desvenlafaxine. It is an extended-release tablet that is film-coated. Each tablet contains 76 mg of Desvenlafaxine succinate, which is equivalent to 50 mg of Desvenlafaxine. The usual dosage should be checked on the package insert. The tablets should be swallowed whole and should not be crushed, cut, chewed, or dissolved. They should be stored at a temperature range of 20° to 25°C (68° to 77°F). A Medication Guide is available online at www.advagenpharma.com/medguide/desvenlafaxineextendedreleasetablets. It is important to keep this medication and all drugs out of the reach of children. The medication is in a package of 500 tablets and is only available with a prescription. The medication is distributed by Advagen Pharma Limited, with their address at 666 Plainsboro Road Suite 605, Plainsboro, NJ, 08536, USA. It is manufactured by Rubicon Research Private Limited in Ambernath, Dist. Thane, 421506 India. The manufacturing license number is KD-682.*

Estimated proportion of patients with relapse (%) over time (days from randomization) for the comparison between Desvenlafaxine and Placebo. The graph shows the range from 0 to 200 days.*